177 related articles for article (PubMed ID: 26983777)
21. Expression of osteonectin/secreted protein acidic and rich in cysteine and matrix metalloproteinases in ameloblastoma.
Shen LC; Chen YK; Hsue SS; Shaw SY
J Oral Pathol Med; 2010 Mar; 39(3):242-9. PubMed ID: 20070483
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
Urayama S
World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin.
Zhao X; Gao S; Ren H; Sun W; Zhang H; Sun J; Yang S; Hao J
Cancer Res; 2014 May; 74(9):2455-64. PubMed ID: 24599125
[TBL] [Abstract][Full Text] [Related]
24. Ukrain affects pancreas cancer cell phenotype in vitro by targeting MMP-9 and intra-/extracellular SPARC expression.
Funel N; Costa F; Pettinari L; Taddeo A; Sala A; Chiriva-Internati M; Cobos E; Colombo G; Milzani A; Campani D; Dalle-Donne I; Gagliano N
Pancreatology; 2010; 10(5):545-52. PubMed ID: 20975318
[TBL] [Abstract][Full Text] [Related]
25. Targeting pancreatic ductal adenocarcinoma acidic microenvironment.
Cruz-Monserrate Z; Roland CL; Deng D; Arumugam T; Moshnikova A; Andreev OA; Reshetnyak YK; Logsdon CD
Sci Rep; 2014 Mar; 4():4410. PubMed ID: 24642931
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in proteomically subtyping pancreatic ductal adenocarcinomas and their potential clinical impact.
Roesli C
Expert Rev Proteomics; 2015 Feb; 12(1):5-8. PubMed ID: 25407217
[TBL] [Abstract][Full Text] [Related]
27. Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials.
Ormanns S; Haas M; Baechmann S; Altendorf-Hofmann A; Remold A; Quietzsch D; Clemens MR; Bentz M; Geissler M; Lambertz H; Kruger S; Kirchner T; Heinemann V; Boeck S
Br J Cancer; 2016 Dec; 115(12):1520-1529. PubMed ID: 27802454
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic stellate cells derived from human pancreatic cancer demonstrate aberrant SPARC-dependent ECM remodeling in 3D engineered fibrotic tissue of clinically relevant thickness.
Tanaka HY; Kitahara K; Sasaki N; Nakao N; Sato K; Narita H; Shimoda H; Matsusaki M; Nishihara H; Masamune A; Kano MR
Biomaterials; 2019 Feb; 192():355-367. PubMed ID: 30476717
[TBL] [Abstract][Full Text] [Related]
29. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
30. Familial Pancreatic Ductal Adenocarcinoma.
Diaz KE; Lucas AL
Am J Pathol; 2019 Jan; 189(1):36-43. PubMed ID: 30558720
[TBL] [Abstract][Full Text] [Related]
31. Microenvironmental factors and extracellular matrix degradation in pancreatic cancer.
Binker MG; Binker-Cosen MJ; Binker-Cosen AA; Cosen-Binker LI
JOP; 2014 Jul; 15(4):280-5. PubMed ID: 25076320
[TBL] [Abstract][Full Text] [Related]
32. Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.
Yoshimura T; Nagahara M; Kuo C; Turner RR; Soon-Shiong P; Hoon DS
Epigenetics; 2011 Aug; 6(8):1001-11. PubMed ID: 21725199
[TBL] [Abstract][Full Text] [Related]
33. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
[TBL] [Abstract][Full Text] [Related]
34. Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer.
Funel N; Giovannetti E; Pollina LE; del Chiaro M; Mosca F; Boggi U; Campani D
Expert Rev Mol Diagn; 2011 Sep; 11(7):695-701. PubMed ID: 21902531
[TBL] [Abstract][Full Text] [Related]
35. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
36. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of SPARC gene expression in patients with gastric cancer.
Sato T; Oshima T; Yamamoto N; Yamada T; Hasegawa S; Yukawa N; Numata K; Kunisaki C; Tanaka K; Shiozawa M; Yoshikawa T; Akaike M; Rino Y; Imada T; Masuda M
J Surg Oncol; 2013 Nov; 108(6):364-8. PubMed ID: 24018911
[TBL] [Abstract][Full Text] [Related]
38. Mechanically stressed cancer microenvironment: Role in pancreatic cancer progression.
Hadden M; Mittal A; Samra J; Zreiqat H; Sahni S; Ramaswamy Y
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188418. PubMed ID: 32827581
[TBL] [Abstract][Full Text] [Related]
39. Toward a better understanding of pancreatic ductal adenocarcinoma: glimmers of hope?
Partensky C
Pancreas; 2013 Jul; 42(5):729-39. PubMed ID: 23648843
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Han W; Cao F; Chen MB; Lu RZ; Wang HB; Yu M; Shi CT; Ding HZ
PLoS One; 2016; 11(1):e0145803. PubMed ID: 26731428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
